caldron 发表于 2025-3-25 03:54:09

http://reply.papertrans.cn/71/7024/702393/702393_21.png

faucet 发表于 2025-3-25 09:55:12

Intraocular Injectable Dosage Form Development: Key Components and Critical Quality Attributes must be identified and successfully incorporated to ensure the medicinal products are effective and safe. These key product characteristics known as Critical Quality Attributes (CQAs) are physical, chemical, biological, or microbiological characteristics that define whether a product has been manuf

滔滔不绝地讲 发表于 2025-3-25 14:47:13

Microbiological Considerations for Ophthalmic Products: Sterility, Endotoxin Limits, and Preservativontrol strategies for sterility, endotoxin, and preservative efficacy to achieve ophthalmic product safety. While finished product testing for sterility or pyrogens confirms the microbiological quality of the products, there are certain challenges in developing a sensitive microbiological test that

Malcontent 发表于 2025-3-25 17:10:04

Packaging Development: Multi-Dose Container Closure for Preservative Free Products, Extractable/Leacs and suspensions in terms of interaction between the product and packaging material. The dropper should be developed with no adverse effects caused by packaging materials. In addition, the dropper should instill the drug into the eyes accurately with no technical difficulties. The dispensing functi

MOAT 发表于 2025-3-25 23:04:37

http://reply.papertrans.cn/71/7024/702393/702393_25.png

难解 发表于 2025-3-26 00:17:05

http://reply.papertrans.cn/71/7024/702393/702393_26.png

思考而得 发表于 2025-3-26 04:47:57

Emulsions for Topical Eye Delivery: State of the Art and Future Perspectivess appropriated ocular dosage forms. However, while once was expecting that emulsion would be used as drug vehicle, surprisingly a new category of products emerged from the market, the artificial tears based on emulsions. Those products are the new generation of artificial tears being now as widely u

步兵 发表于 2025-3-26 12:22:34

Microparticle Products for the Eye: Preformulation, Formulation, and Manufacturing Considerationsverse effects. One of the main challenges in the ophthalmological therapy is to decrease the number of interventions. Intraocular drug delivery systems (IDDS) emerge as a therapeutic tool for long-term delivery of therapeutic molecules including as main components biopolymers and active substances (

竖琴 发表于 2025-3-26 13:12:25

http://reply.papertrans.cn/71/7024/702393/702393_29.png

prick-test 发表于 2025-3-26 19:50:30

Advanced Hydrogel Formulations for the Eyear hydrogels and dendrimer hydrogels. Mechanisms underlying the formation of those hydrogels and their applications for medication of ocular diseases are reviewed. Supramolecular hydrogels form on the basis of host-guest interactions. Dendrimer hydrogels are comprised of well-defined hyperbranched d
页: 1 2 [3] 4 5 6 7
查看完整版本: Titlebook: Ophthalmic Product Development; From Bench to Bedsid Seshadri Neervannan,Uday B. Kompella Book 2021 American Association of Pharmaceutical